Mark Iwicki
2022
In 2022, Mark Iwicki earned a total compensation of $1.9M as Chief Executive Officer at Kala Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
| Bonus | $409,266 |
|---|---|
| Option Awards | $770,803 |
| Salary | $682,110 |
| Other | $6,120 |
| Total | $1,868,299 |
Iwicki received $770.8K in option awards, accounting for 41% of the total pay in 2022.
Iwicki also received $409.3K in bonus, $682.1K in salary and $6.1K in other compensation.
Rankings
In 2022, Mark Iwicki's compensation ranked 1,847th out of 5,505 executives tracked by ExecPay. In other words, Iwicki earned more than 66.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,847 out of 5,505 | 66th |
Division Manufacturing | 970 out of 2,984 | 68th |
Major group Chemicals And Allied Products | 401 out of 1,339 | 70th |
Industry group Drugs | 366 out of 1,242 | 71st |
Industry Pharmaceutical Preparations | 261 out of 896 | 71st |
Source: SEC filing on March 13, 2023.
Iwicki's colleagues
We found two more compensation records of executives who worked with Mark Iwicki at Kala Pharmaceuticals in 2022.